Martin Windpessl
banner
m-windp.bsky.social
Martin Windpessl
@m-windp.bsky.social
Nephrologist, Austria
Danish cohort study backing this assumption: Bonnesen K, et al. Effectiveness of Empagliflozin vs Dapagliflozin for Kidney Outcomes in Type 2 Diabetes. JAMA Intern Med. 2025 Mar 1;185(3):314-323. PMID: 39836391
October 21, 2025 at 5:25 PM
Congrats, Christoph!
August 19, 2025 at 5:12 PM
Reposted by Martin Windpessl
Brilliant. Great example of a well chosen topic for a ten tips CKJ article 👌

@ckj-era.bsky.social

academic.oup.com/ckj/advance-...
10 tips on how to take a proper family history in CKD patient care
Abstract. Patients with chronic kidney disease (CKD) often present with a family burden of disease. However, efficient collection and documentation of fami
academic.oup.com
August 8, 2025 at 11:44 AM
Thanks-so important! Fooled me once, saw it mentioned in surgical textbooks occasionally but never found a good reference. Any suggestions?
April 25, 2025 at 3:08 AM
Pimpernell?
April 19, 2025 at 7:43 PM
Sauerampfer 3. von links?
April 19, 2025 at 6:09 PM
NEJM; January 22, 1998
April 11, 2025 at 4:01 AM
This more broadly also applies to the whole anticoagulation-dialysis-conundrum in general😉
December 23, 2024 at 5:04 PM
There is also a very recent review on this important issue (with no clear-cut recommendations either): Afsar B, Am J Cardiovasc Drugs. 2024 Oct 30. PMID: 39476316.
December 23, 2024 at 4:50 PM
Yes, in 25!
December 16, 2024 at 5:45 PM
Viribus unitis!
As always: Thanks for guidance (and patience), Andreas!
December 4, 2024 at 4:00 PM